Trial intelligence / Profile preview

Oral curcumin for symptom relief in oral lichen planus

IRCT201607032950N4Phase 3Completed

Sponsor
Guilan University of Medical Sciences
Start
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of curcumin in oral lichen planus (OLP), sponsored by Guilan University of Medical Sciences. Primary endpoints: Change in lesion size, Change in pain and 1 more. Started Jul 2016; status: completed.

02

Drugs

curcumin
03

Conditions

oral lichen planus (OLP)

Beyond the preview

Go deeper on IRCT201607032950N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201607032950N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call